Pathology specialist contributes to debate on breast cancer gene screening
Tuesday, November 25, 2014 - 15:30
in Health & Medicine
What are the risks and benefits of screening for BRCA1 and BRCA2 mutations in the general adult population? An expert has published an invited commentary on this issue.